Form 4 for PCRX Pacira BioSciences, Inc.
Accepted 2025-08-04 00:00:00 ET · period of report 2025-08-01 · accession 0001396814-25-000095 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-08-04 | 2025-08-01 | PCRX | SLONIN JONATHAN | Chief Medical Off | F - Tax | $22.07 | -315 | 182.3K | -0.2% | -$6,952 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-08-01 | F | D | 315 | $22.07 | 182,327.01 | D | — | — | (F2) Includes 682.498 shares of common stock acquired under the issuer's employee stock purchase plan in June 2025. |